KCM
EXAS

Knoll Capital Management’s Exact Sciences EXAS Stock Holding History

Knoll Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-14,000
Closed -$165K – 15
2013
Q3 		$165K Buy
+14,000
New +$180K 0.09% 10

Other funds holding EXAS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Knoll Capital Management's EXAS Position: Q4 2013 in Review

Knoll Capital Management sold out of Exact Sciences (EXAS) in Q4 2013, closing a stake of 14,000 shares — an estimated $165K sold.

Knoll Capital Management first reported a position in EXAS in Q3 2013 and held it in 1 quarter. The position peaked at $165K in Q3 2013. 131 funds tracked by Wall St. Rank hold EXAS as of Q4 2013.

  • Knoll Capital Management reported no remaining Exact Sciences position as of Q4 2013 after selling out during the quarter.
  • Knoll Capital Management sold 14,000 Exact Sciences shares in Q4 2013, an estimated $165K.
  • Knoll Capital Management first reported a position in Exact Sciences in Q3 2013 and held it in 1 quarter.
  • Knoll Capital Management's Exact Sciences position peaked at $165K in Q3 2013.
  • 131 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2013.

Based on Knoll Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.